FDA Approves Generic Version of Xalatan® Eye Drops for Glaucoma

April 4, 2011

Mylan Inc. today announced that the FDA has approved its Latanoprost Ophthalmic Solution, 0.005%, a generic version of Xalatan® eye drops for treatment of glaucoma.

The product represents Mylan’s first ophthalmic solution.

Click here for the full press release.

 

 



Comments

Jump down to form below to submit your own comments

Trackback URL
http://eyedocnews.com/005191-fda-approves-generic-version-of-xalatan%c2%ae-eye-drops-for-glaucoma/trackback/

Have insights to contribute? Please submit your comment below